Olicard Retard (Isosorbide Mononitrate)

Olicard Retard, a nitrate class medication, is employed in the management of several cardiovascular conditions.

• Chronic stable angina: Improves exercise tolerance and reduces frequency of angina attacks.
• Heart failure with preserved ejection fraction: May alleviate symptoms related to myocardial oxygen imbalance.
• Prophylaxis of angina pectoris: Prevents episodes of chest pain during physical exertion.

• Isosorbide mononitrate is absorbed and converted to nitric oxide, which activates guanylate cyclase in vascular smooth‑muscle cells. The resulting rise in cyclic GMP causes vasodilation of veins and arteries, lowering preload and afterload, and thereby decreasing myocardial oxygen consumption.

Adverse reactions to isosorbide mononitrate vary in frequency and severity.

Common Side Effects

• Headache: Often transient and may lessen with continued therapy.
• Flushing: Warm sensation, typically mild.
• Dizziness or light‑headedness: Related to blood‑pressure reduction.
• Nausea: Mild gastrointestinal upset.
• Fatigue: General tiredness without exertion.
• Palpitations: Sensation of irregular heartbeat.

Serious or Rare Side Effects

• Severe hypotension: Marked drop in blood pressure causing fainting.
• Methemoglobinemia: Unusual discoloration of skin and mucous membranes.
• Allergic reactions: Rash, itching, swelling, or anaphylaxis.
• Syncope: Sudden loss of consciousness.
• Chest pain worsening: Paradoxical increase in angina.
• Renal impairment exacerbation: Decline in kidney function in susceptible patients.

When prescribing Olicard Retard, clinicians should consider several safety measures.

• Cardiovascular assessment: Evaluate blood pressure and heart rate before initiation.
• Concomitant nitrates: Avoid combined use to prevent severe hypotension.
• Phosphodiesterase‑5 inhibitors: Do not co‑administer due to risk of profound vasodilation.
• Hepatic impairment: Use cautiously; dose adjustment may be required.
• Elderly patients: Monitor for dizziness and falls.
• Store at ambient temperature: Keep below 25°C in the original container, protected from moisture.

Isosorbide mononitrate interacts with several drug classes that can modify its hemodynamic effects.

Major Interactions (Avoid)

• Other nitrates (e.g., nitroglycerin): May cause additive hypotensive effects.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): Heightened risk of severe blood‑pressure fall.
• Antihypertensive agents: Combined therapy can lead to excessive blood‑pressure reduction.

Moderate Interactions (Monitor Closely)

• Diuretics: May amplify orthostatic hypotension.
• Alcohol: Can increase vasodilatory response and dizziness.
• Certain antibiotics (e.g., macrolides): May affect metabolism and plasma levels.